Medicure
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medicure generated cash of $2,079,000, which is more than the previous year. Cash used in financing activities reached the amount of -$297,000 last year. Net change in cash is therefore $1,512,000.
Cash Flow
| 2014 | 473.96K | -41.00K | 10.45K |
|---|---|---|---|
| 2015 | 142.79K | -226.57K | 3.11M |
| 2016 | 6.41M | -42.17M | 44.51M |
| 2017 | 21.92M | 54.15M | -82.97M |
| 2018 | 742.27K | 19.65M | -2.65M |
| 2019 | -14.64M | 34.28M | -30.26M |
| 2020 | -2.24M | -7.24M | -766K |
| 2021 | 3.98M | -2.69M | -316K |
| 2022 | 1.82M | -310K | -355K |
| 2023 | 2.07M | -270K | -297K |
MPH.V Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.85M | 3.69M | 2.71M | 12.96M | 24.13M | 5.26M | 12.26M | 3.56M | 493.86K | 126.61K |
Operating activities | ||||||||||
Net income | -922K | 1.36M | -727K | -6.84M | -19.78M | 3.92M | 43.42M | 27.65M | 1.66M | 2.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.17M | 2.05M | 3.14M | 2.77M | 1.92M | 299.18K | 7.80M | 2.38M | 690.93K | 742.54K |
Stock-based compensation expense | 288K | 47K | 135K | 317K | 417K | 0 | 623.11K | 1.40M | 1.46M | 1.06M |
| Deferred income tax benefit | 288K | 47K | 135K | 317K | 417K | 0 | 623.11K | 1.40M | 1.46M | 1.06M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 760K | -864K | 593K | 5.08M | -318K | -1.34M | -3.71M | -4.17M | -8.18M | -1.18M |
Inventories | -31K | 166K | 471K | 723K | -4.07M | -1.25M | 145.33K | 2.52M | -1.23M | -433.79K |
Accounts payable | -236K | 568K | 20K | -3.80M | -4.15M | 7.13M | 48.50M | 1.17M | 4.63M | 0 |
Cash generated by operating activities | 2.07M | 1.82M | 3.98M | -2.24M | -14.64M | 742.27K | 21.92M | 6.41M | 142.79K | 473.96K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -6.33M | -44.1M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -310K | -818K | -2K | -13.84M | -1.47M | -1.32M | -464.20K | -226.57K | -28.65K |
Acquisitions Net | 0 | 0 | -1.87M | -7.23M | -13.66M | 65.23M | 55.47M | -41.71M | 0 | 0 |
Cash generated by investing activities | -270K | -310K | -2.69M | -7.24M | 34.28M | 19.65M | 54.15M | -42.17M | -226.57K | -41.00K |
Financing activities | ||||||||||
Common Stock Issued | 56K | 0 | 0 | 0 | 0 | 363.45K | 1.03M | 1.88M | 3.63M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -522K | -30.28M | -3.02M | 0 | 0 | 0 | 0 |
Repayments of term debt | -353K | -355K | -316K | -244K | 0 | 0 | -75.12M | -10.46K | -694.44K | 0 |
Cash used in financing activities | -297K | -355K | -316K | -766K | -30.26M | -2.65M | -82.97M | 44.51M | 3.11M | 10.45K |
Net Change In Cash | 1.51M | 1.16M | 978K | -10.24M | -11.17M | 18.87M | -7.00M | 8.69M | 3.07M | 107.68K |
Cash at end of period | 6.36M | 4.85M | 3.69M | 2.71M | 12.96M | 24.13M | 5.26M | 12.26M | 3.56M | 234.29K |